Bayer’s oral FXIa inhibitor…
Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk [...]
Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk [...]
Hundreds of industry leaders have signed a letter to FDA [...]
The FDA is hiring more than 1,000 new employees and [...]
No matter who Fierce could pull aside for a quick [...]
Nurix Therapeutics is trimming its workforce not long after launching [...]
Contineum Therapeutics’ M1 receptor antagonist has failed to move the [...]
Gilead’s general counsel and EVP of corporate affairs Deborah Telman [...]
Moderna, an mRNA specialist known for its COVID-19 vaccine Spikevax, [...]
Pfizer has released the full data from its phase 3 [...]
Genetic medicines outfit Ensoma is halving its workforce, with most [...]